Serum insulin-like growth factor-1 levels in neurodegenerative diseases.

Keisuke SuzukiShiho SuzukiYuko IshiiHiroaki FujitaTakeo MatsubaraMadoka OkamuraHirotaka SakuramotoKoichi Hirata

Published in: Acta neurologica Scandinavica (2019)

We found correlations of serum IGF-1 levels with frontal lobe and striatal dopaminergic function and disability in PD patients and with disability in AD patients. The usefulness of measuring serum IGF-1 levels for monitoring disease progression in neurodegenerative diseases requires further studies.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
multiple sclerosis
peritoneal dialysis
prognostic factors